N-[(5-fluoro-2,3-dihydro-1-benzofuran-4-yl)methyl]-8-(4-methylimidazol-1-yl)-[1,2,4]triazolo[4,3-c]pyrimidin-5-amine
C18H16FN7O — CID 121412524
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(5-fluoro-2,3-dihydro-1-benzofuran-4-yl)methyl]-8-(4-methylimidazol-1-yl)-[1,2,4]triazolo[4,3-c]pyrimidin-5-amine
N-[(5-fluoro-2,3-dihydro-1-benzofuran-4-yl)methyl]-8-(4-methylimidazol-1-yl)-[1,2,4]triazolo[4,3-c]pyrimidin-5-amine (PubChem CID 121412524) has the molecular formula C18H16FN7O and a molecular weight of 365.37 g/mol. Its IUPAC name is N-[(5-fluoro-2,3-dihydro-1-benzofuran-4-yl)methyl]-8-(4-methylimidazol-1-yl)-[1,2,4]triazolo[4,3-c]pyrimidin-5-amine.
Molecular Properties
| Compound Name | N-[(5-fluoro-2,3-dihydro-1-benzofuran-4-yl)methyl]-8-(4-methylimidazol-1-yl)-[1,2,4]triazolo[4,3-c]pyrimidin-5-amine |
|---|---|
| PubChem CID | 121412524 |
| Molecular Formula | C18H16FN7O |
| Molecular Weight | 365.37 g/mol |
| Exact Mass | 365.14 |
| IUPAC Name | N-[(5-fluoro-2,3-dihydro-1-benzofuran-4-yl)methyl]-8-(4-methylimidazol-1-yl)-[1,2,4]triazolo[4,3-c]pyrimidin-5-amine |
| SMILES | Cc1cn(-c2cnc(NCc3c(F)ccc4c3CCO4)n3cnnc23)cn1 |
| InChI | InChI=1S/C18H16FN7O/c1-11-8-25(9-22-11)15-7-21-18(26-10-23-24-17(15)26)20-6-13-12-4-5-27-16(12)3-2-14(13)19/h2-3,7-10H,4-6H2,1H3,(H,20,21) |
| InChIKey | DNXQPHQAMCRLAS-UHFFFAOYSA-N |
| XLogP | 2.30 |
| TPSA | 82.16 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 365.37 |
| LogP ≤ 5 | 2.30 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 121412524 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.